Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant

Objective/background: Clostridium difficile infection (CDI) is a potential complication during hematopoietic stem cell transplantation (HSCT), and no specific recommendations exist regarding treatment of CDI in allogeneic SCT patients. Use of metronidazole and oral vancomycin has been associated wit...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Laura Prohaska, Zahra Mahmoudjafari, Leyla Shune, Anurag Singh, Tara Lin, Sunil Abhyankar, Siddhartha Ganguly, Dennis Grauer, Joseph McGuirk, Lisa Clough
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2018-10-01
Serie:	Hematology/Oncology and Stem Cell Therapy
Soggetti:	allogeneic stem cell transplantation clostridium difficile fidaxomicin vancomycin
Accesso online:	https://journals.lww.com/10.1016/j.hemonc.2018.05.001
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!